EAN News

EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved!

Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!

The Lancet Neurology highlights the urgent need to prioritise brain health in a new editorial, citing the Brain Health Mission as an example of positive initiatives aiming to promote brain health.  

Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.

The EAN is proud to host the European Brain Health Summit 2025 on 19 March, from 09:00 to 12:00 CET, both onsite in Brussels, and streaming live via EAN.org

Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors.

Take our EAN 2025 Congress Quiz for your chance to win free registration for the 11th Congress of the European Academy of Neurology!

Prof. Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology (starting July 2025) talks about her plans for the journal's future, as part of our series celebrating its 30th anniversary.

The EAN is pleased to announce that Prof. Claudia Sommer will be the next Editor-in-Chief of our flagship journal, the European Journal of Neurology. Read about her plans for the journal, here.

EAN President, Prof. Elena Moro, looks back at some highlights of a successful 10th anniversary year for the EAN, and ahead to some exciting plans for 2025.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for December 2024.

Our paper of the month highlights the findings of the stage 2 interim analysis from the first cycle of MND SMART, a phase 3, multi-arm, randomised, adaptive platform trial conducted across 20 centres in the UK.

The EAN welcomes the European Medicine Agency’s decision to approve lecanemab for the treatment of early Alzheimer's disease, which provides a much-needed treatment opportunity for this devastating condition.

It is with profound sadness that we announce the loss of Prof. Giancarlo Comi, former president of the European Neurological Society (ENS), a leading figure in the neurological community, and an inspiring example to neurologists and researchers worldwide.

The EAN is pleased to announce the establishment of the European Journal of Neurology Jes Olesen Award, recognising exceptional research in the field of neurology and related specialties.